Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-TNFRSF18, MEDI-1873 Vector   (CAT#: GTVCR-WQ1877MR)

This product GTVCR-WQ1877MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting TNFRSF18. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_004195.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 8784
UniProt ID Q9Y5U5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-TNFRSF18, MEDI-1873 Vector (GTVCR-WQ1877MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ505MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL33, ANB020 Vector Vector ANB020
GTVCR-WQ388MR IVTScrip™ pT7-VEE-mRNA-Anti-C5, ALXN1007 Vector Vector ALXN1007
GTVCR-WQ22MR IVTScrip™ pSP6-VEE-mRNA-Anti-H1-0, (131)I-chTNT-1/B Vector Vector (131)I-chTNT-1/B
GTVCR-WQ1570MR IVTScrip™ pSP6-VEE-mRNA-Anti-PDCD1, INCMGA-00012 Vector Vector INCMGA-00012
GTVCR-WQ893MR IVTScrip™ pSP6-VEE-mRNA-Anti-ALCAM, CD166 AADC Vector Vector CD166 AADC
GTVCR-WQ762MR IVTScrip™ pSP6-VEE-mRNA-Anti-CXCL10, BMS-936557 Vector Vector BMS-936557
GTVCR-WQ1294MR IVTScrip™ pSP6-VEE-mRNA-Anti-ERBB2, GEXMab73 Vector Vector GEXMab73
GTVCR-WQ1039MR IVTScrip™ pT7-VEE-mRNA-Anti-CD40, CP-870893 Vector Vector CP-870893
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.